Patents by Inventor Anna JU

Anna JU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODY SPECIFICALLY BINDING TO B7-H3
    Publication number: 20260201038
    Abstract: The present disclosure relates to an anti-B7-H3 antibody or an antigen-binding fragment thereof, which binds to a specific epitope located within the amino acid sequence of a domain of B7-H3. The antibody (i) specifically binds to various types of cancer cell lines expressing B7-H3, demonstrating T cell-mediated cancer cell-killing effect, and (ii) binds to epitopes in both humans and mice, thus allowing for effective evaluation of anticancer effect in preclinical trials when developed into a therapeutic antibody.
    Type: Application
    Filed: November 15, 2023
    Publication date: July 16, 2026
    Applicant: CELLABMED INC.
    Inventors: Anna JU, Min-Gu KIM, Boram LEE, Sangeun LEE, Yeongha JEON, Song-Jae LEE, Seong-Won SONG, Ji Chul LEE, Sung-Won MIN, Won Hye KA, Hyeong Sun KWON, Kyung Hee RHEE, Gong-Deuk BAE, Nam Hyuk KIM, Jineui LEE
  • Immunocytes expressing a chimeric antigen receptor binding to cancer cells and TNF-related apoptosis-inducing ligand (trail)
    Patent number: 11649282
    Abstract: Provided are a genetically modified immunocyte expressing a chimeric antigen receptor (CAR) comprising an antigen binding domain specifically binding to cancer cells and/or expressing TRAIL, a composition for preventing or treating cancer, the composition comprising the immunocytes, a cell therapeutic agent, a method of providing information for cancer diagnosis, and a method of preparing the genetically modified immunocyte.
    Type: Grant
    Filed: March 10, 2020
    Date of Patent: May 16, 2023
    Assignees: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY, THE ASAN FOUNDATION, UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION
    Inventors: Mihue Jang, Eunsung Jun, Anna Ju
  • IMMUNOCYTES WITH IMPROVED CANCER-FIGHTING ABILITY
    Publication number: 20210371515
    Abstract: Provided are a genetically modified immunocyte expressing a chimeric antigen receptor (CAR) comprising an antigen binding domain specifically binding to cancer cells and/or expressing TRAIL, a composition for preventing or treating cancer, the composition comprising the immunocytes, a cell therapeutic agent, a method of providing information for cancer diagnosis, and a method of preparing the genetically modified immunocyte.
    Type: Application
    Filed: March 10, 2020
    Publication date: December 2, 2021
    Applicants: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY, THE ASAN FOUNDATION, UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION
    Inventors: Mihue JANG, Eunsung JUN, Anna JU